Free Trial

Aethlon Medical (AEMD) Competitors

Aethlon Medical logo
$0.38 0.00 (-1.26%)
(As of 10:15 AM ET)

AEMD vs. PRPO, MDAI, IINN, PYPD, LFWD, MHUA, MBOT, NEPH, AMIX, and VVOS

Should you be buying Aethlon Medical stock or one of its competitors? The main competitors of Aethlon Medical include Precipio (PRPO), Spectral AI (MDAI), Inspira Technologies Oxy B.H.N. (IINN), PolyPid (PYPD), ReWalk Robotics (LFWD), Meihua International Medical Technologies (MHUA), Microbot Medical (MBOT), Nephros (NEPH), Autonomix Medical (AMIX), and Vivos Therapeutics (VVOS).

Aethlon Medical vs.

Aethlon Medical (NASDAQ:AEMD) and Precipio (NASDAQ:PRPO) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends, earnings, risk and community ranking.

Aethlon Medical currently has a consensus price target of $7.00, indicating a potential upside of 1,674.40%. Given Aethlon Medical's stronger consensus rating and higher possible upside, analysts clearly believe Aethlon Medical is more favorable than Precipio.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aethlon Medical
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Precipio
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Aethlon Medical has a beta of 1.74, indicating that its stock price is 74% more volatile than the S&P 500. Comparatively, Precipio has a beta of 1.42, indicating that its stock price is 42% more volatile than the S&P 500.

2.0% of Aethlon Medical shares are held by institutional investors. Comparatively, 10.5% of Precipio shares are held by institutional investors. 1.1% of Aethlon Medical shares are held by insiders. Comparatively, 13.3% of Precipio shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Aethlon Medical has a net margin of 0.00% compared to Precipio's net margin of -17.23%. Precipio's return on equity of -34.01% beat Aethlon Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Aethlon MedicalN/A -160.36% -115.74%
Precipio -17.23%-34.01%-25.27%

In the previous week, Aethlon Medical had 8 more articles in the media than Precipio. MarketBeat recorded 10 mentions for Aethlon Medical and 2 mentions for Precipio. Precipio's average media sentiment score of 1.37 beat Aethlon Medical's score of 0.06 indicating that Precipio is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Aethlon Medical
1 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
Precipio
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Precipio has higher revenue and earnings than Aethlon Medical. Precipio is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aethlon Medical$570K9.66-$12.21M-$2.82-0.14
Precipio$15.20M0.58-$5.85M-$1.83-3.28

Precipio received 54 more outperform votes than Aethlon Medical when rated by MarketBeat users. Likewise, 73.32% of users gave Precipio an outperform vote while only 52.28% of users gave Aethlon Medical an outperform vote.

CompanyUnderperformOutperform
Aethlon MedicalOutperform Votes
218
52.28%
Underperform Votes
199
47.72%
PrecipioOutperform Votes
272
73.32%
Underperform Votes
99
26.68%

Summary

Precipio beats Aethlon Medical on 10 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AEMD vs. The Competition

MetricAethlon MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$5.51M$4.42B$5.06B$8.82B
Dividend YieldN/A41.17%5.18%4.07%
P/E Ratio-0.1424.81126.3117.81
Price / Sales9.6647.031,178.7474.57
Price / CashN/A51.8733.8632.53
Price / Book0.184.974.684.68
Net Income-$12.21M$13.76M$119.54M$226.08M
7 Day Performance-1.00%-1.08%-1.83%-1.04%
1 Month Performance-3.17%0.58%-3.60%1.04%
1 Year Performance-76.45%50.91%31.91%26.28%

Aethlon Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AEMD
Aethlon Medical
2.6602 of 5 stars
$0.39
-1.3%
$7.00
+1,718.2%
-77.2%$5.38M$570,000.00-0.1410
PRPO
Precipio
1.2245 of 5 stars
$6.00
-2.3%
N/A-15.8%$8.88M$15.20M0.0060Positive News
Gap Down
MDAI
Spectral AI
2.7744 of 5 stars
$1.09
+2.8%
$4.50
+312.8%
-59.4%$20.26M$18.06M0.0078
IINN
Inspira Technologies Oxy B.H.N.
0.3151 of 5 stars
$1.37
+3.8%
N/A+11.3%$17.29MN/A0.0020News Coverage
PYPD
PolyPid
2.8681 of 5 stars
$3.49
-3.1%
$12.00
+243.8%
-14.3%$16.75MN/A0.0080Positive News
High Trading Volume
LFWD
ReWalk Robotics
3.5648 of 5 stars
$1.86
+0.5%
$13.00
+598.9%
N/A$16.39M$13.85M-0.7460Gap Down
MHUA
Meihua International Medical Technologies
0.3475 of 5 stars
$0.64
-1.4%
N/A-66.4%$16.05M$97.10M0.00620Gap Up
MBOT
Microbot Medical
1.7232 of 5 stars
$0.94
+2.3%
$7.00
+644.1%
-32.8%$15.93MN/A-1.1520Negative News
NEPH
Nephros
2.2003 of 5 stars
$1.50
-5.7%
$5.00
+233.3%
-24.3%$15.81M$14.24M0.0030Gap Up
AMIX
Autonomix Medical
2.2386 of 5 stars
$13.48
+0.9%
$28.00
+107.7%
N/A$15.50MN/A0.001
VVOS
Vivos Therapeutics
2.1857 of 5 stars
$2.87
-0.7%
$6.30
+119.5%
-34.2%$13.89M$13.80M0.00160Analyst Forecast

Related Companies and Tools


This page (NASDAQ:AEMD) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners